Although CYLD mutations have been shown to be present in sporadic and syndromic cylindromas [13], molecular characterization of cylindrocarcinomas, beyond their occasional association with syndromes of germline CYLD mutation, is limited to characterizations of TP53 alterations [60, 61]. This evidence concerns the gene CYLD and adnexal spiradenoma/cylindroma of a sweat gland.